COVID-19 and Regenerative Medicine

Published 2020-04-13

AARM is participating in a number of clinical research efforts in the realm of COVID-19 pulmonary disease. AARM sees an urgent need to develop Regenerative Medicine protocols for pulmonary and cardiac regeneration following severe COVID-19 disease. Current data suggests that a significant number of patients who survive severe bilateral COVID-19 pneumonia show residual pulmonary impairment and heart failure.

Search our Directory

AABRM Members are not only experts in regenerative medicine but offer a wide range of related products, services and related-procedures in that field. Search our extensive Member Directory to find a Member near you.

Member Directory

American Society of Regenerative Medicine Logo

Excellence.  Education.  Research.  Practice.